表面等离子共振(SPR)生物传感器 2010

The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.

BMC structural biology Solbak SM, Reksten TR, Wray V, Bruns K, Horvli O, Raae AJ, Henklein P, Henklein P, Röder R, Mitzner D, Schubert U, Fossen T
阅读原文 PDF DOI PubMed

组成图示

The intriguing cyclophilin A-HIV-1 Vp... 传感器构成示意图

点击图片查看大图 · 依据论文自动绘制

传感器类型

表面等离子共振(SPR)生物传感器

检测对象

HIV-1 Vpr N端肽(HIV-1 Vpr N-terminal peptides, sVpr);样品基质:HBS-P buffer pH 7.4中的合成肽溶液。

检测原理

重组人CypA通过胺偶联固定于CM5 SPR芯片表面,作为识别配体。将不同序列的合成HIV-1 Vpr N端肽溶于HBS-P缓冲液并注入流动相。当肽含有以Pro-35为中心的RHFPRIW基序时,与CypA发生特异性结合,形成CypA-Vpr复合物;结合过程可能伴随构象变化,并与CypA催化Pro-35顺反异构相关。表面结合质量增加导致SPR共振条件改变,Biacore T100记录响应单位(RU)随时间变化:结合相上升、解离相下降。分析物浓度越高,结合量越大,响应信号越强。不含Pro-35的sVpr1-20或P35N突变体不产生稳定结合信号,因为瞬时酶-底物异构化复合物寿命太短,SPR无法检测。

检测灵敏度

未报告LOD、线性范围、灵敏度斜率、相关系数。

效应效果

SPR显示选择性依赖Pro-35:sVpr1-20和P35N突变体不结合CypA;含Pro-35的sVpr21-40、sVpr25-40、sVpr1-40、sVpr30-40、sVpr32-38结合,KD为1.67×10^-4–4.87×10^-4 M。七肽sVpr32-38(RHFPRIW)仍维持强结合,sVpr33-37明显减弱(KD 0.00357 M)。P5,10,14N可结合但KD 0.00615 M,ka1超出仪器范围,可能受溶解度影响。NMR在酶/底物比最高672:1下检测到CypA催化Pro-5、-10、-14、-35顺反异构,环孢素A消除交换峰;Pro-35互变速率0.19±0.01 s^-1。未报告RSD、回收率或方法对比。作者认为结果支持CypA作为分子伴侣参与HIV-1复制,为抗逆转录病毒药物设计提供依据。

传感器的构成

  • 基底/换能器:CM5 research-grade sensor chip(金基SPR芯片)与Biacore T100光学系统,提供表面等离子共振换能。
  • 修饰/固定层:standard amine-coupling chemistry形成的胺偶联界面,用于固定CypA。
  • 识别元件:重组人Cyclophilin A(CypA),固定于CM5芯片,捕获含Pro-35的Vpr N端肽。
  • 分析物:合成HIV-1 Vpr N端肽(sVpr1-20、sVpr21-40、sVpr25-40、sVpr1-40、sVpr30-40、sVpr32-38、sVpr33-37及突变体),溶于HBS-P buffer pH 7.4。
  • 参考/扣除通道:FC1/FC3未固定CypA的参考流路,扣除bulk buffer effects与unspecific binding。
  • 信号读出:Biacore T100记录sensogram(RU),2.5 Hz,60 s association、120 s dissociation。

中文摘要

环孢素A(CypA)是抗逆转录病毒治疗的潜在靶点,抑制CypA可抑制HIV-1复制,但其调控HIV-1感染性的机制仍不清楚。HIV-1病毒蛋白R(Vpr)与CypA在体外和体内均可相互作用,但CypA与Vpr N端Pro-35相互作用的性质尚未明确。本研究结合核磁共振(NMR)交换光谱和表面等离子共振(SPR)光谱,表征人CypA与HIV-1 Vpr N端肽的相互作用。原子分辨率NMR表明,CypA可催化Vpr高度保守的Pro-5、-10、-14和-35发生脯氨酸顺反异构,且所需异构酶浓度远低于肽底物。在Vpr N端肽中,只有含Pro-35的肽在生物传感器实验中结合CypA。SPR研究显示,以Pro-35为中心、由RHFPRIW组成的七残基基序足以维持强特异性结合。结果表明,Pro-35对CypA-Vpr特异性结合至关重要,而所有脯氨酸残基的顺反异构仅涉及瞬时酶-底物相互作用;SPR数据符合结合过程中伴随构象变化的两态结合模型,支持CypA作为分子伴侣参与HIV-1毒力的模型。

英文摘要

BACKGROUND: Cyclophilin A (CypA) represents a potential target for antiretroviral therapy since inhibition of CypA suppresses human immunodeficiency virus type 1 (HIV-1) replication, although the mechanism through which CypA modulates HIV-1 infectivity still remains unclear. The interaction of HIV-1 viral protein R (Vpr) with the human peptidyl prolyl isomerase CypA is known to occur in vitro and in vivo. However, the nature of the interaction of CypA with Pro-35 of N-terminal Vpr has remained undefined. RESULTS: Characterization of the interactions of human CypA with N-terminal peptides of HIV-1 Vpr has been achieved using a combination of nuclear magnetic resonace (NMR) exchange spectroscopy and surface plasmon resonance spectroscopy (SPR). NMR data at atomic resolution indicate prolyl cis/trans isomerisation of the highly conserved proline residues Pro-5, -10, -14 and -35 of Vpr are catalyzed by human CypA and require only very low concentrations of the isomerase relative to that of the peptide substrates. Of the N-terminal peptides of Vpr only those containing Pro-35 bind to CypA in a biosensor assay. SPR studies of specific N-terminal peptides with decreasing numbers of residues revealed that a seven-residue motif centred at Pro-35 consisting of RHFPRIW, which under membrane-like solution conditions comprises the loop region connecting helix 1 and 2 of Vpr and the two terminal residues of helix 1, is sufficient to maintain strong specific binding. CONCLUSIONS: Only N-terminal peptides of Vpr containing Pro-35, which appears to be vital for manifold functions of Vpr, bind to CypA in a biosensor assay. This indicates that Pro-35 is essential for a specific CypA-Vpr binding interaction, in contrast to the general prolyl cis/trans isomerisation observed for all proline residues of Vpr, which only involve transient enzyme-substrate interactions. Previously suggested models depicting CypA as a chaperone that plays a role in HIV-1 virulence are now supported by our data. In detail the SPR data of this interaction were compatible with a two-state binding interaction model that involves a conformational change during binding. This is in accord with the structural changes observed by NMR suggesting CypA catalyzes the prolyl cis/trans interconversion during binding to the RHFP35RIW motif of N-terminal Vpr.